Evidence map›Paper›PMID 34590615›Full record

ArticleCurrent oncology (Toronto, Ont.)2021

Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients.

Matthias Mäurer, Katharina Pachmann, Thomas Wendt, Dorothea Schott, Andrea Wittig

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Matthias MäurerDepartment of Radiotherapy and Radiation Oncology, University Hospital Jena, Bachstraße 18, 07743 Jena, Germany.ORCID 0000-0001-9662-3082
Katharina PachmannTransfusion Center Bayreuth, Kurpromenade 2, 95448 Bayreuth, Germany.
Thomas WendtDepartment of Radiotherapy and Radiation Oncology, University Hospital Jena, Bachstraße 18, 07743 Jena, Germany.
Dorothea SchottTransfusion Center Bayreuth, Kurpromenade 2, 95448 Bayreuth, Germany.
Andrea WittigDepartment of Radiotherapy and Radiation Oncology, University Hospital Jena, Bachstraße 18, 07743 Jena, Germany.
Jena University Hospital · DEBayreuth Medical Center · DE

Funding

Deutsche Forschungsgemeinschaft WI 830/12-1
6 · The paper itself

Abstract

Circulating epithelial tumor cells (CETC) are considered to be responsible for the formation of metastases. Therefore, their importance as prognostic and/or predictive markers in breast cancer is being intensively investigated. Here, the reliability of single cell expression analyses in isolated and collected CETC from whole blood samples of patients with early-stage breast cancer before and after radiotherapy (RT) using the maintrac

Indexed as

Breast NeoplasmsNeoplasms, Glandular and EpithelialFemaleGene ExpressionHumansOrganotin CompoundsPilot ProjectsProspective StudiesRadiotherapy, AdjuvantReproducibility of Resultsbis(beta-carboxyethyl)tin dichlorideOrganotin Compoundscirculating tumor cellsearly-stage breast cancergene expression analysisprognostic markerradiotherapy

Identifiers

PMID34590615
PMCPMC8482075
OpenAlexW3197469777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.